ADMA vs JNJ: Which Stock is Better?
Side-by-side comparison of ADMA Biologics Inc and Johnson & Johnson in 2026
ADMA
ADMA Biologics Inc
—
JNJ
Johnson & Johnson
$232.77
Key Metrics Comparison
| Metric | ADMA | JNJ | Winner |
|---|---|---|---|
| Market Cap | $4.39B | $375.37B | JNJ |
| P/E Ratio | 21.90 | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ADMA
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADMA or JNJ a better investment?
Comparing ADMA and JNJ: ADMA Biologics Inc has a market cap of $4.39B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADMA and JNJ?
ADMA (ADMA Biologics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADMA or JNJ?
Based on P/E ratios, JNJ trades at a lower multiple (17.4x vs 21.9x).
Which is growing faster: ADMA or JNJ?
Both ADMA and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ADMA or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ADMA or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $4.39B for ADMA.
Should I buy ADMA or JNJ in 2026?
Both ADMA and JNJ have investment merit. ADMA trades at $N/A while JNJ trades at $232.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADMA and JNJ stock?
Key differences: Market Cap ($4.39B vs $375.37B), P/E Ratio (21.9x vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ADMA or JNJ in 2026?
The choice between ADMA and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ADMA and JNJ?
ADMA (ADMA Biologics Inc) has a market cap of $4.39B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.